CONTACT INFORMATION

Do you wish to exhibit at this event? If so click here
 

Beryllium Summit 2011:
4th International Conference on Beryllium Disease


October 20-22, 2011

InterContinental Hotel and Bank of America Conference Center
Cleveland, Ohio
 

Register Online Today

Print this Content

 

 

 

 

Description

The conference will cover recent innovations in the prevention, evaluation, and management of chronic beryllium disease including primary, secondary, and tertiary preventive strategies for this exposure-related disease.

This conference will also provide a review and analysis of current research, new treatment strategies, and clinical practice management options with the goal of increasing practitioners’ knowledge and competencies and, thus, reducing the incidence and complications of beryllium disease.

Key topics

  • Human health effects of beryllium     
  • Beryllium exposure                            
  • Immunology and pathogenic mechanisms
  • Genetics, genomics, and gene environmental interactions 
  • Future directions

Back to Top

 

Target Audience

Designed for pulmonologists, occupational medicine practitioners, medical directors and health and safety managers of beryllium-using facilities, industrial hygienists, government workers and regulators, and health care professionals involved in the diagnosis and clinical management of patients with beryllium sensitization and chronic beryllium disease.

Back to Top

 

Objectives

  • Perform a differential diagnosis of chronic beryllium disease in patients with a history of environmental exposure to beryllium;
  • Compare and contrast recent advances in diagnostic tests for chronic beryllium disease;
  • Describe current research findings in the genomics associated with beryllium sensitization;
  • Summarize pathogenesis of immunology and pathogenic mechanisms associated with development of chronic beryllium disease;
  • Describe exposure pathways and biological relevance;
  • Define the role of beryllium sensitization in chronic beryllium disease.

Back to Top
 

Call for Abstracts

The organizing committee for the Beryllium Summit 2011: 4th International Conference on Beryllium Disease is currently accepting abstracts / posters.

Click Here To Submit Your Abstract

Suggested Topic Categories – (not limited to these suggestions)

  • Human Health Effects of Beryllium
  • Beryllium Exposure
  • Immunology and Pathogenic Mechanisms
  • Genetics, Genomics, and Gene Environmental Interactions

Opening and Deadline
The call for abstracts submission opened August 1, 2011. The deadline for abstract submissions is 5:00 pm ET on September 20, 2011.

Review Process
Abstracts will be reviewed for compliance with the instructions then assigned a number to ensure anonymity. Each abstract/poster is reviewed by the organizing committee for quality and content. Submitting authors of selected abstracts/posters will be notified of acceptance via email. Authors must be present at their posters during the assigned sessions(s) to talk with Conference participants. Authors of abstracts selected for podium presentation are required to give an oral presentation with slides. Slides must be submitted by Monday, October 3, 2011. Authors must submit their financial disclosure.

Acceptance and Registration
Authors of accepted abstracts must register for the Conference by October 3, 2011. If you need a formal acceptance letter for visa, contact Beth Viscomi at 216.448.0692. 

General Abstract Information
Authors may submit abstracts/posters of completed work, work in progress, or work presented at a local or regional level. Abstracts presented elsewhere within the 12 months prior to the submission deadline will be accepted. The primary author is responsible for obtaining written consent from all authors and appropriate institutions prior to submitting an abstract/poster.

Abstracts/posters must be free of commercial bias. In addition, they may not imply an endorsement of any service by their institution or the Cleveland Clinic.

Authors should pay close attention to formatting instructions. All research papers submitted must be formatted according to guidelines.

Abstract/Poster Submission
Submissions by fax or mail are not permitted.  Upon abstract/poster acceptance, submitting author will be notified.

Official Language
Papers must be submitted and presented in English.

Author Affiliation
Authors from different institutions should be identified by a numeral within the process.

Text of the Abstract/Poster
A. Text, including headings, may not exceed 2 letter size (8 ½” x 11”) pages.  Please use 11-point Arial font.

B. The use of standard abbreviations is acceptable. Other abbreviations should be placed in parentheses, after the first appearance of the full word(s) for which it stands.

C. Topic: Abstracts/posters must relate to Beryllium.

For Additional Abstract Information
Please contact Beth Viscomi:  216.448.0692 or 800.238.6750 (viscomb@ccf.org)

Click Here To Submit Your Abstract

 

Director

Raed A. Dweik, MD
Professor of Medicine
Respiratory Institute
Cleveland Clinic
Cleveland, OH

 

Back to Top

 

Planning Committee

Lisa Barker, BS
Beryllium Program Lead
Division of Environmental and Occupational Health Sciences
National Jewish Health
Denver, CO

Chantal Dion, PhD
Laboratory Services and Expertise
Research Department
Institut de recherche Robert-Sauvé en santé et en sécurité du travail (IRSST)
Montréal (Québec), Canada

Lisa A. Maier, MD, MSPH
Professor of Medicine
Division of Pulmonary Sciences and Critical Care Medicine
University of Colorado Health Sciences Center
Chief, Division of Environmental and Occupational Health Sciences
National Jewish Health
Denver, CO

Lee S. Newman, MD, MA
Professor
Department of Preventive Medicine and Biometrics
Department of Medicine
Division of Pulmonary Science and Critical Care Medicine
Division of Allergy & Clinical Immunology
University of Colorado at Denver and Health Sciences Center
Denver, CO

Milton D. Rossman, MD
Professor of Medicine
Perelman School of Medicine
University of Pennsylvania
Pulmonary, Allergy and Critical Care Division
Hospital of the University of Pennsylvania
Philadelphia, PA  

Christine R. Schuler, PhD
Research Epidemiologist
Division of Respiratory Disease Studies
National Institute for Occupational Safety and Health
Centers for Disease Control and Prevention
Morgantown, WV

Back to Top

 

Faculty

Michael J. Brisson      
Group Manager, Analytical Laboratories
Savannah River Nuclear Solutions LLC
Savannah River Site
Aiken, SC

Donna L. Cragle, PhD
Epidemiologist
Oak Ridge Institute for Science and Education
Oak Ridge, TN

Daniel A. Culver, DO, FCCP
Department of Pathobiology
Lerner Research Institute
Respiratory Institute
Cleveland Clinic
Cleveland, OH

Kristin J. Cummings, MD, MPH
Medical Officer
National Institute for  Occupational Safety and Health
Centers for Disease Control and Prevention
Morgantown, WV

Brian J. Day, PhD
Integrated Department of Immunology
Vice Chair of Research, Department of Medicine
National Jewish Health Center
Denver, CO

Amanda Edens
Deputy Director
Directorate of Standards and Guidance
Occupational Safety and Health Administration
Washington, DC

Carol F. Farver, MD
Director, Pulmonary Pathology
Section Head, Surgical Pathology
Department of Anatomic Pathology
Pathology and Laboratory Medicine Institute
Cleveland Clinic
Cleveland, OH

Elizabeth Fireman, PhD                                  
Pofessor of Occupational and Environmental Health
Tel Aviv Sourasky Medical Center
Tel Aviv, Israel

Andrew P. Fontenot, MD
Henry N. Claman Professor of Medicine
Division Head
University of Colorado Denver
Aurora, CO

Mark D. Hoover, PhD, CHP, CIH
Division of Respiratory Disease Studies
National Institute for Occupational Safety and Health
Centers for Disease Control and Prevention
Morgantown, WV

Rachel P. Leiton
Director
Division of Energy Employees Occupational Illness
Compensation
Washington, DC

Thomas M. McCleskey, PhD
Group Leader
Material Chemistry Group
Los Alamos National Laboratory
Los Alamos, NM

Dannie C. Middleton, MD, MPH
Medical Epidemiologist
Division of Health Studies
Agency for Toxic Substance and Disease
  Registry
Atlanta, GA

Dimitri S. Monos, PhD
Director, Immunogenetics Laboratory
The Children's Hospital of Philadelphia
Professor of Pathology and Laboratory Medicine University of Pennsylvania School of Medicine
Philadelphia, PA

Peggy M. Mroz, MSPH
Epidemiologist
Division of Environmental and Occupational Health Sciences
National Jewish Health
Science Transforming Life
Denver, CO

Joachim Müller-Quernheim, MD, PhD
Department of Pneumology
University of Freiberg Medical Center
Freiburg, Germany

Gaston Ostiguy
Montreal Chest Institute
McGill University Health Centre
Montréal (Québec), Canada

Cesare Saltini, PhD
Professor of Pulmonary Fibrosis and Rare Diseases
University Hospital Policlinico Tor Vergata
Viale Oxford, Rome, Italy

Janet Shorter, RN
Building Trades National Medical Screening Program
Oak Ridge, TN

Lori J. Silveira, PhD
Division of Biostatistics and Bioinformatics
Department of Medicine
National Jewish Health
Denver, CO

Carmen M. Swaisgood, PhD
Project Staff
Department of Pulmonary, Allergy and Critical Care Medicine
Respiratory Institute
Department of Pathobiology
Lerner Research Institute
Cleveland Clinic
Cleveland, OH
                                                           
Tim K. Takaro, MD, MPH, MS
Associate Professor
Associate Dean for Research
Faculty of Health Sciences
Simon Fraser University
Burnaby, BC, Canada

James S. Taylor, MD
Department of Dermatology
Dermatology and Plastic Surgery Institute
Cleveland Clinic
Cleveland, OH

Mike Van Dyke, PhD, CIH
Senior Industrial Hygienist
Assistant Professor
Division of Environmental and Health Sciences
National Jewish Health
Denver, CO

M. Abbas Virji, ScD, MSc, CIH
Research Industrial Hygienist
Division of Respiratory Disease Studies
National Institute for Occupational Safety and Health
Centers for Disease Control and Prevention
Morgantown, WV

Ainsley Weston, PhD

Associate Director for Science
Division of Respiratory Disease Studies
National Institute for Occupational Safety and Health
Centers for Disease Control and Prevention
Morgantown, WV

Herbert P. Wiedemann, MD, MBA
Chairman, Respiratory Institute
Cleveland Clinic
Cleveland, OH

Belinda Yen-Lieberman, PhD
Clinical Pathology
Pathology and Laboratory Medicine Institute
Cleveland Clinic
Cleveland, OH

Back to Top

 

Agenda

Thursday, Oct. 20   |   Friday, Oct.21   |   Saturday, Oct.22

THURSDAY, OCTOBER 20, 2011
7:00 am Registration / Continental Breakfast
8:00 am Welcome - Herbert Wiedemann, MD
8:10 am Overview and Goals of the Meeting - Raed Dweik, MD
  Human Health Effects of Beryllium
8:15 am Clinical Overview and Advances in Beryllium Sensitization and Chronic Beryllium Disease Diagnosis and Management - Raed Dweik, MD
8:45 am Disease Severity and Treatment - Milton Rossman, MD
9:15 am Lung Pathology in Chronic Beryllium Disease - Carol Farver, MD
9:45 am Refreshment Break
10:00 am Optimizing BeLPT Criteria for Beryllium Sensitization - Dan Middleton, MD
10:30 am Beryllium Lymphocyte Proliferation Test (BeLPT) Primer - Belinda Yen-Lieberman, PhD
11:00 am National Supplemental Screening Program - Donna Cragle, PhD
11:30 am New Tests for Detecting Beryllium Sensitization - Andrew Fontenot, MD
12:00 pm Overview of Recent Epidemiologic Studies - Peggy Mroz, MSPH
12:30 pm Lunch
1:30 pm Energy Employees Occupational Illness Compensation Program - Rachel Leiton  
2:00 pm Treatment of CBD: Lessons Learned from Sarcoidosis - Dan Culver, DO
  Beryllium Exposure
2:30 pm Exposure Pathways  - M. Abbas Virji, ScD
3:00 pm Beryllium and the Skin: A Dermatologic Perspective - James Taylor, MD
3:30 pm Refreshment Break 
3:45 pm Biologically Relevant Exposures to Beryllium - M. Abbas Virji, ScD
4:15 pm Beryllium BioRepository and Opportunities for Research - Lee Newman, MD
5:00 pm Abstract Presentations
Back to Top  
FRIDAY, OCTOBER 21, 2011
7:30 am Registration / Continental Breakfast
  Immunology and Pathogenic Mechanisms
8:00 am   Development of a Sarcoidosis Murine Lung Granuloma Model Using Mycobacterium Superoxide Dismutase A - Carmen Swaisgood, PhD
8:45 am The Role of Oxidative Stress in Chronic Beryllium Disease - Brian Day, PhD
9:15 am Abstract Presentations
10:30 am Refreshment Break
11:00 am Beryllium Disease and Sensitization: The Quebec Experience 1990-2011- Gaston Ostiguy, MD
 11:45 am Using Administrative Databases to Find Beryllium Disease Risk in British Columbia - Tim Takaro, MD
12:30 pm Lunch
  Exposure Characteristics, Internal Dosimetry
1:30 pm Reassessing the Current Exposure Limits - Amanda Edens
2:00 pm Physicochemical Characterization of Beryllium - Mark Hoover, PhD
2:30 pm Beryllium Binding and Chemistry - T. Mark McCleskey, PhD
3:00 pm Lung Deposition Model - Mark Hoover, PhD
3:30 pm Refreshment Break
3:45 pm Induced Sputum Analyses in Beryllium-Exposed Dental Technicians - Elizabeth Fireman, PhD
4:15 pm Beryllium Health and Safety Committee Activities and Research Needs - Mike Brisson
Back to Top  
SATURDAY, OCTOBER 22, 2011
7:30 am Registration / Continental Breakfast
  Genetics, Genomics, and Gene-Environment Interactions
8:00 am Genome-Wide Search for the Detection of Genes Associated with Immune Mediated Diseases - Dimitri Monos, PhD
8:30 am Predictive Value of HLA-DPB1 Alleles- Ainsley Weston, PhD
9:00 am The Genetics of Be-MHC Binding - Cesare Saltini, PhD
9:30 am Contribution of Exposure and Genetics to the Development of Beryllium Sensitization and Chronic Beryllium Disease - Mike Van Dyke, PhD
10:00 am Refreshment Break
10:15 am The Genetics of Severe Lung Disease - Lori Silveira, PhD
10:45 am Preventing Sensitization and Disease from Beryllium Exposure - Christine Schuler, PhD
  Updates: Future Directions
11:15 am What Beryllium Can Teach the Indium Industry - Kristin Cummings, MD
11:45 am Development of German Evidence-Based Occupational Health Guidelines for Chronic Beryllium Disease - Joachim Müller-Quernheim, MD, PhD
12:15 pm American Thoracic Society Consensus Statement Update - Lisa Maier, MD
12:45 pm Lunch
  Patient Perspective
1:45 pm Patient and Worker Oriented Session
Moderator:  Raed Dweik, MD

Panel:   Lisa Barker, BS
Lisa Maier, MD
Milton Rossman, MD
Janet Shorter, RN
Rachel Leiton

  Closing Session
3:15 pm     Symposium Summary  - Lisa Maier, MD
3:30 pm Closing Remarks - Raed Dweik, MD
3:45 pm Adjourn

Back to Top

 

Location

InterContinental Hotel and Bank of America Conference Center
9801 Carnegie Avenue
Cleveland, OH 44106
Phone: 216.707.4100 or 877.707.8999


View Larger Map

Back to Top

 

Hotel Accommodations

A block of rooms has been reserved at the InterContinental Hotel until 5:00 PM ET, September 19, 2011. To make your reservations, contact the Hotel Reservations Department at 216.707.4000 or 1.877.707.8999. Please identify yourself as being with the Cleveland Clinic Beryllium Summit 2011: 4th Annual International Conference on Beryllium Disease.

Special rates are listed below:

  • InterContinental Conference Hotel, $189 single/double plus tax (online code REL)
  • InterContinental Suite Hotel, $169 single/double plus tax (online code D06)

The InterContinental Conference Hotel is located at 9801 Carnegie Avenue, on the campus of the Cleveland Clinic. The Suite Hotel is located at 8800 Euclid Avenue and is within walking distance to the InterContinental Hotel and Bank of America Conference Center.

Back to Top

 

Ground Transportation

Taxi service is available from Cleveland Hopkins International Airport to the InterContinental Hotel and Bank of America Conference Center.

Back to Top

 

Parking

Parking is available in the East 100th St. Carnegie Avenue Visitor's Parking Garage at prevailing rates. Valet parking is available at the hotel for an additional charge.

Back to Top

 

Additional Information

For further information about the course, contact Cleveland Clinic Center for Continuing Education at:

Local: 216.448.0770
Toll Free: 800.238.6750

For questions about registering online, call 216.448.0777 or email CMEregistration@ccf.org.

Back to Top

 

Faculty Disclosure

The Cleveland Clinic Foundation Center for Continuing Education has implemented a policy to comply with the current Accreditation Council for Continuing Medical Education Standards for Commercial Support requiring resolution of all faculty conflicts of interest. Faculty declaring a relevant commercial interest will be identified in the activity syllabus.

Back to Top

 

Americans with Disabilities Act

The Cleveland Clinic Foundation Center for Continuing Education fully intends to comply with the legal requirements of the Americans with Disabilities Act. If you need assistance, please notify us at least two weeks prior to the activity. 

Back to Top

 

Accreditation

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this live activity for a maximum of 22.0 AMA PRA Category 1 Credits. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association Council on Continuing Medical Education for Category 2 credit.

Cleveland Clinic (OH-045/10-1-12) is an approved provider of continuing nursing education by the Ohio Nurses Association (OBN-001-91), an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

Back to Top

 

 

Online Registration/Fees
 

Register Online Today

Category Full Event Per Day
Physician $750.00 $285.00
Corporate $750.00 $285.00
CCF Comprecare $487.50 $205.00
CCF Alumni $450.00 $185.00
Resident / Fellow $450.00 $185.00
Nurse Practitioner / Nurse / Allied Health Professional / Physician Assistant / Other $450.00 $185.00
CCHS Physician $750.00 $285.00
CCHS Fellow / Resident $225.00 $115.00
CCHS Nurse Practitioner / Nurse / Allied Health Professional / Physician Assistant / Other $225.00 $115.00
CCF Physician $375.00 $165.00
CCF Resident / Fellow $225.00 $115.00
CCF Nurse Practitioner / Nurse / Allied Health Professional / Physician Assistant / Other $225.00 $115.00

Register Online Today

Please call 216.448.0777 for per day registration

Back to Top

Cancellation Policy
Preregistrations are accepted by fax or online until 4:00 pm ET October 18, 2011. Please register onsite after this date. In case of cancellation, a full refund will be made if canceled by Tuesday, October 11, 2011. After October 11, 2011, a $100 cancellation fee will be deducted from your refund. Written notification of your cancellation is required to process your refund.

NO REFUNDS WILL BE ISSUED AFTER November 30, 2011.

For questions about registration, please call 216.448.0777 or email us at cmeregistration@ccf.org.

 
Bookmark this Chapter
Copyright © 2000-2014 The Cleveland Clinic Foundation. All Rights Reserved.
Center for Continuing Education | 9500 Euclid Avenue, KK31, Cleveland, OH 44195
Copyright © 2000-2014 The Cleveland Clinic Foundation. All Rights Reserved.
Center for Continuing Education | 9500 Euclid Avenue, KK31, Cleveland, OH 44195